Aarey Drugs and Pharmaceuticals has informed that there is no deviation / variation in the utilisation of the proceeds in respect Preferential issue of Equity Shares of the Company in accordance with the Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statement of deviation/variation is enclosed.
The above information is a part of company’s filings submitted to BSE.